Aging and Health Research
Total Page:16
File Type:pdf, Size:1020Kb
AGING AND HEALTH RESEARCH AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 2667-0321 DESCRIPTION . Aims Aging and Health Research (AHR) is an international, peer-reviewed open access journal that publishes articles from a global research community. The aims of this journal is to establish an innovative forum of global aging and health research to advance knowledge in diverse disciplines to promote early detection, diagnosis, treatment, and intervention of chronic diseases; to disseminating knowledge for optimal translation of research findings into policy and practical settings; to communicate new ideas, findings, perspectives, and research directions; to advocate public policies promoting aging and health in a global context. Scope Aging and Health Research (AHR) welcomes the submission of original and review articles, short communications and perspectives/commentaries. The topics of this journal are relevant to interdisciplinary investigations, integrative and translational articles, related to: diagnosis, treatment, etiology, risk factors, early detection, prognosis, clinical interventions, prevention, and new models of health services in aging related diseases and health status. An online-only journal, AHR is focused on pharmacology, nursing, epidemiology, public health, dentistry, behavior, neurology, psychiatry, gerontology, geriatrics, social work, global health, sociology, allied health, health services research, health economics, political science, and public policy. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Editor in Chief Ding Ding, Fudan University, Shanghai, China Population-based and hospital-based epidemiological studies of neurological diseases (such as stroke, dementia, epilepsy, Parkinson's disease, essential trauma, migraine and autism), including etiology, risk factors, prognosis, genetic, biomarkers, intervention, big-data analysis, health economic analysis. Bei Wu, New York University Rory Meyers College of Nursing, New York, New York, United States of America Long-term care, cognitive impairment, public health dentistry, global aging, and health disparities. AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/ahr 1 Editorial Board Members Shakeel Ahmad Ramay, Sustainable Development Policy Institute, Islamabad, Pakistan Changing Global dynamics, Digital Diplomacy, China, Belt and Route Initiative, SCO, UN, Economics, Climate Change Amy Renee Borenstein, University of California San Diego, La Jolla, California, United States of America Epidemiology; Dementias of Late Life; Risk Factors from Early Life; Alzheimer's disease, Parkinson's disease, Multiple Sclerosis Yang Cao, Örebro University, Orebro, Sweden Neuroepidemiology, environmental epidemiology, cancer epidemiology, nutrition epidemioloygy, randomized controlled trials, causal inference, prediction models, machine learning, deep learning, network analysis methods, data visualization Mary W. Carter, Towson University College of Health Professions, Towson, Maryland, United States of America Nursing Home Quality, Hospitalization, Injury, Emergency department use, Healthcare Use and Costs Evandro Fang, University of Oslo, Oslo, Norway Alzheimer’s disease, entorhinal cortex, NAD+, autophagy, Mitophagy, ageing, DNA repair Qiushi Feng, National University of Singapore Centre for Family and Population Research Faculty of arts and Social Sciences, Singapore, Singapore Economic Sociology, Population Research, Aging and Health Man Mehndiratta, Govind Ballabh Pant Hospital, New Delhi, India Epilepsy, Stroke and Demyelinating dISORDERS James A. Mortimer, Carlsbad, United States of America Neuroepidemiology and Epidemiology of Alzheimer’s Disease Mary Evelyn Northridge, NYU Langone Health, New York, New York, United States of America Oral health, health equity, epidemiology, social determinants of health AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/ahr 2 GUIDE FOR AUTHORS . INTRODUCTION Types of article The categories of articles that are published in this journal are listed and described below. Please select the category that best describes your paper. If your paper does not fall into any of these categories, please contact the Editorial Office. Original articles These articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, cohort studies, cost-effectiveness analyses, case-control studies, and surveys with high response rates, which represent new and significant contributions to translational research in the field of Aging and health research. They should include an abstract and be structured as follows: Abstract, Introduction, Materials and Methods, Results, Discussion, Conflicts of Interest Statement, Funding/Support Statement, Acknowledgements (if any), References, Figures and Tables (if any), and Supplementary Material (if any). The Abstract should be structured as Background, Methods, Results and Conclusions, and with no more than 250 words. The Introduction should provide a brief background to the subject of the paper, explain the importance of the study, and state a precise study question or purpose. The Materials and Methods section should describe the study design and methods (including the study setting and dates, patients/participants with inclusion and exclusion criteria, the essential features of any exposures or interventions, the main outcome measures, or data sources and how these were selected for the study), and state the statistical procedures employed in the research. The Results section should comprise the study results presented in a logical sequence, supplemented by tables and/or figures. Take care that the text does not repeat data that are presented in tables and/or figures. Only emphasize and summarize the essential features of the main results. The Discussion section should be used to emphasize the new and important aspects of the study, placing the results in context with published literature, the strength and limitation of the study, the implications of the findings, and the conclusions that follow from the study results. An original article should have a running title. The text should be limited to 5000 words upon submission (including title, abstract, tables, figures, and references list) with not more than 5 figures/ tables and 40 references. During a potential revisions stage, after peer-review, authors can extend the article length to a maximum of 7,000 words to better address the reviewers and editors' comments. The journal does not accept original articles of case reports and case series. Review articles These should provide a balanced synthesis of current knowledge and constructive suggestions on Aging and health research related themes. They should cover aspects of a topic in which scientific consensus exists as well as aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated. Reviews shall have a maximum length of 6,000 words upon submission (the word count limit includes title, abstract, tables, figures, and references list). They should have an abstract of not more than 200 words, not more than 80 references and up to 8 figures/tables. During a potential revisions stage, after peer-review, authors can extend the article length to a maximum of 8,000 words to better address the reviewers and editors' comments. Letters to the Editor Letters provide readers with an opportunity to raise issues of interest or to respond to an article previously published in the AHR. Letters should provide new information or a fresh perspective on the previously published article. Letters should be less than 1000 words, with not more than 10 references and 2 figures/tables. Letters are sent to the author(s) of the previously published article under discussion for their response. Brief Communications These reports should be concise presentations of preliminary experimental results, instrumentation and analytical techniques, or aspects of clinical or experimental practice that are not fully investigated, verified or perfected but which may be of widespread interest or application. The Editors reserve the right to decide what constitutes a Brief Communication. Brief Communications should have unstructured Abstract with less than 150 words. The text should be less than 1500 words, with no more than 20 references, and 2 Tables/Figures. AUTHOR INFORMATION PACK 29 Sep 2021 www.elsevier.com/locate/ahr 3 Commentaries Commentaries may address a topic related to an article recently published or forthcoming in the journal. Commentaries are intended to address issues of substantive concern to the field, to convey opinions, and stimulate dialogue. Commentaries do not have an abstract, should generally be limited to 1,500 words, and may include 2 tables/figures and up to 20 references. Commentaries are usually invited by the Editors in Chief. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated